Beacon Biosignals raises $86M in Series B funding led by Innoviva and Google Ventures to scale its technology for neurobiomarker discovery.
PRIVATENov 13, 2025
Amount Raised
$86 Million
Round Type
Series B
BostonInformation TechnologySoftware
Investors
Catalio Capital ManagementS32TakedaNexus Neurotech VenturesGeneral CatalystGVIndicator VenturesLogos CapitalCasdin CapitalInnoviva
Description
Beacon Biosignals, a Boston-based neurotechnology company, raised $86M in Series B funding. The funds will be utilized to scale technology and operations aimed at enhancing neurobiomarker discovery. Investors include Innoviva, Google Ventures, and multiple others. This financing brings total funding to over $121M.
Who to call at Beacon Biosignals, and when
A new round usually means Beacon Biosignals is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Beacon Biosignals raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Beacon Biosignals, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Beacon Biosignals
Location
80 REVERE ST., #10
Boston, Massachusetts, United States
About
Beacon's machine learning platform for EEG enables and accelerates new treatments that transform the lives of patients with neurological, psychiatric or sleep disorders. Through novel machine learning algorithms, large datasets, and advances in software engineering, Beacon Biosignals is changing the way patients are treated for disorders of the brain.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Beacon Biosignals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
BostonInformation TechnologySoftware